Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metmore GV 2mg/500mg/0.20mg Tablet

Prescription Icon
Prescription Required

Marketer

Morepen Laboratories Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.20mg)

Overview Metmore GV 2mg/500mg/0.20mg Tablet

DiabetaComb 2mg/500mg/0.20mg tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by managing blood glucose levels. DiabetaComb 2mg/500mg/0.20mg tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor; lifestyle choices are vital for diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by symptoms such as sweating, dizziness, headache, and tremors. Knowing how to manage this, including regular meals and carrying a fast-acting glucose source (e.g., sugary snacks or juice), is essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before use. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring, along with periodic blood tests to evaluate blood cell counts and liver function, are recommended by your doctor.

Uses of Metmore GV 2mg/500mg/0.20mg Tablet

Managing Type 2 diabetes

Major Benefits of Metmore GV 2mg/500mg/0.20mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Metmore GV 2mg/500mg/0.20mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

Common Side effects of Metmore GV 2mg/500mg/0.20mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Metmore GV 2mg/500mg/0.20mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Metmore GV 2mg/500mg/0.20mg tablets on an empty stomach.

How Metmore GV 2mg/500mg/0.20mg Tablet works:

Each Metmore GV tablet (2mg/500mg/0.20mg) combines three distinct anti-diabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Metmore GV 2mg/500mg/0.20mg Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metmore GV 2mg/500mg/0.20mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers before prescribing this medication. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Metmore GV 2mg/500mg/0.20mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

Individuals with kidney impairment should likely refrain from using Metmore GV 2mg/500mg/0.20mg tablets due to potential safety concerns. Medical advice is recommended. The use of Metmore GV 2mg/500mg/0.20mg tablets is contraindicated in those with severe kidney disease.

LiverLiverCAUTION

Individuals with liver impairment should use Metmore GV 2mg/500mg/0.20mg Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is unsuitable for patients with severe liver dysfunction.

What if you forget to take Metmore GV 2mg/500mg/0.20mg Tablet :

Should you forget a dose of Metmore GV 2mg/500mg/0.20mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metmore GV 2mg/500mg/0.20mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metmore GV 2mg/500mg/0.20mg Tablet

Metmore GV 2mg/500mg/0.20mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This triple-drug therapy, used alongside diet and exercise, improves blood glucose control. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, while voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 DM.
Metmore GV 2mg/500mg/0.20mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infections.
Metmore GV 2mg/500mg/0.20mg Tablets are contraindicated in patients allergic to any component or excipient. Use is also contraindicated in those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol with Metmore GV 2mg/500mg/0.20mg Tablets is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Metmore GV 2mg/500mg/0.20mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, as directed on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Metmore GV 2mg/500mg/0.20...
105
MRP 121
13% off